“Protein Tyrosine Phosphatases: Emerging Targets for Cancer Immunotherapy with Recent Advances in Inhibitors and Degraders”

https://pubmed.ncbi.nlm.nih.gov/38116815

Protein tyrosine phosphatases are emerging targets for cancer immunotherapy, with recent advances in developing small molecule inhibitors and degraders as novel agents.